Public-registry site landscape for NCT07742735, a Short Bowel Syndrome (SBS) study sponsored by VectivBio AG. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07742735 (registry record) |
| Sponsor | VectivBio AG |
| Condition(s) | Short Bowel Syndrome (SBS); SBS Associated With Intestinal Failure (SBS-IF) |
| Phase | PHASE3 |
| Listed sites | 94 |
| Site countries | United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Czechia, Denmark, France, Germany, Hungary |
Eichor generates a preliminary site-risk snapshot for NCT07742735 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →